Ziprasidone N-Oxide | CAS 188797-76-4 - Request Quote
Ziprasidone N-Oxide
| SZ CAT No: | SZ-Z002012 |
| CAS No | 188797-76-4 |
| Mol.F. | C21H21ClN4O2S |
| Mol.Wt. | 428.9 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ziprasidone N-Oxide is chemically 4-(benzo[d]isothiazol-3-yl)-1-(2-(6-chloro-2-oxoindolin-5-yl)ethyl)piperazine 1-oxide. Ziprasidone N-Oxide is supplied with detailed characterization data compliant with regulatory guideline. Ziprasidone N-Oxide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pharmaceutical Reference Standards.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 188797-76-4
Purchase 188797-76-4
Order 188797-76-4
Enquire 188797-76-4
price of 188797-76-4
188797-76-4 Supplier
188797-76-4 Manufacturer
188797-76-4 Exporter
buy high quality Ziprasidone N-Oxide
Purchase Ziprasidone N-Oxide
Ziprasidone N-Oxide suppliers
Ziprasidone N-Oxide manufacturers
Ziprasidone N-Oxide price
Order Ziprasidone N-Oxide
Enquire Ziprasidone N-Oxide
Ziprasidone N-Oxide cost
Ziprasidone N-Oxide Supplier
Ziprasidone N-Oxide Distributor
Ziprasidone N-Oxide for Method Validation
Pharmaceutical Reference Standards Reference Standard
Ziprasidone N-Oxide for ANDA Filing
Ziprasidone N-Oxide for Forced Degradation Studies
Ziprasidone N-Oxide Identification Standards
Ziprasidone N-Oxide for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.